Diabetes mellitus is a metabolic disease that is associated with hyperglycemia affecting various organ systems of the body. One of the most dreaded complications of this disease is the diabetic foot. The diabetic foot is the end result of multiple causal pathways, which include peripheral neuropathy and vascular disease. The problem is compounded by the increased incidence of infection. This article deals with the various pathogenic pathways associated with the development of the diabetic foot.
Wild S., Roglic G., Green A., Sicree R., King H.Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
2.
Ramachandran A., Snehalatha C., Kapur A., et al. Diabetes epidemiology study group in India: high prevalence of diabetes and impaired glucose tolerance in India . Diabetologia. 2001;44:1094-1101.
3.
Amos AF, McCarty DJ, Zimmet P.The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(suppl 5):581-585.
4.
Pendsey SPUnderstanding diabetic foot. Int J Diabetes Dev Ctries . 2010;30:75-79.
5.
Armstrong DG , Lavery LADiabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998 ;57: 1325-1332, 1337-1338.
6.
Bowering CKDiabetic foot ulcers: pathophysiology, assessment, and therapy. Can Fam Physician. 2001;47:1007-1016.
7.
Leese GPReview: the varied attractions of the diabetic foot. Br J Diab Vasc Dis. 2009;9:155-159.
8.
Boulton AJThe pathway to ulceration: aetiopathogenesis. In: Cavanagh PR, ed. The Foot in Diabetes. Chicester, UK: Wiley;2000:19-31.
9.
Abbot CA, Vileikyte L., Williamson S., Carrington AL, Boulton AJMulticenter study of the incidence and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21:1071-1075.
10.
Zochodone DWDiabetic polyneuropathy: an update. Curr Opin Neurol. 2008;21:527-533.
Levin MEAn overview of the diabetic foot: pathogenesis, management and prevention of lesions. Int J Diabetes Dev Ctries. 1994 ;14:39-47.
13.
Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ III, Obrien PCRisk factors for severity of diabetic polyneuropathy. Diabetes Care. 1999;22:1479-1486.
14.
Veves A., Manes C., Murray HJ, Young MJ, Boulton AJM.Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993;16:1187-1189.
15.
Chandalia HB , Singh D., Kapoor V., Chandalia SH, Lamba PSFootwear and foot care knowledge as risk factors for foot problems in Indian diabetics. Int J Diabetes Dev Ctries. 2008 ; 28:109-113.
16.
Veves A., Murray HJ, Young MJ, Boulton AJThe risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992;35:660-663.
17.
Feldman EL, Russelll JW, Sullivan KA. Golovoy D.New insights into the pathogenesis of diabetic neuropathy. Curr Opin Neurol. 1999;5:553-563.
18.
Huijberts MS , Schaper NC, Schalkwijk CGAdvanced glycation end products and diabetic foot disease. Diabetes Metab Res Rev. 2008 ;24(suppl 1):S19-S24.
19.
Reiber GE, Vileikyte L., Boyko EJ, et al. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22:157-162.
20.
Viswanathan V., Thomas N., Tandon N., et al. Profile of diabetic foot and its associated complications. J Assoc Physicians India. 2005 ;53:933-936.
21.
Palumbo PJ, Melton LJ III.Peripheral vascular disease and diabetes.In Diabetes in America: Diabetes Data Compiled in 1984. Chapter XV. Washington, DC: Government Printing Office ; 1985. NIH Publication No. 85-1468.
22.
Paraskevas KI, Baker DM, Pompella A., Mikhailidis DPDoes diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview. Ann Vasc Surg. 2008;22:481-491.
23.
Gershater MA , Londahl M., Nyberg P., et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52:398-407.
24.
Geerlings SE , Hoepelman AIImmune dysfunction in patients with diabetes mellitus. FEMS Immunol Med Microbiol. 1999 ; 26:259-265.
25.
Delamaire M. , Maugendre D., Moreno M., Le Goff MC, Alannic H., Genetet B.Impaired leucocyte function in diabetic patients . Diabet Med. 1997;14:29-34.
26.
Ting X., Lu S., Mani R.Diabetic foot infection in the world: we need ways forward. Int J Low Extrem Wounds. 2010;9:3-5.
Bansal E., Garg A., Bhatia S., Attri AK, Chander J.Spectrum of microbial flora in diabetic foot ulcers. Indian J Pathol Microbiol. 2008;51:204-208.
29.
Dang CN, Prasad YD, Boulton AJ, Jude EBMethicillin resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med. 2003;20:159-161.
30.
Gadepalli RG , Dhawan B., Sreenivas V., et al. A clinicomicrobiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29:1727-1732.
31.
Bristow IR, Spruce MCFungal foot infection, cellulites and diabetes: a review. Diabet Med. 2009;26:548-551.
32.
Reyzelman AM , Armstrong DG, Vayser DJ, Hadi SA, Harkless LB, Hussain SKEmergence of non-group A streptococcal necrotizing diabetic foot infections. J Am Podiatr Med Assoc. 1998;88:305-307.
